OPKO Health to Sell Select BioReference Assets to Labcorp for $722MZacks Investment Research · Oct 16, 2026
OPKO Health Sheds Diagnostics Businesses in Major Labcorp DealBenzinga · Oct 15, 2026
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthPRNewsWire · Oct 15, 2026
Comparing Ardent Health (NYSE:ARDT) & OPKO Health (NASDAQ:OPK)Defense World · Oct 7, 2026
OPKO Health, Inc. (NASDAQ:OPK) Stock Now Rated “Hold” by Sell-Side AnalystsDefense World · Oct 3, 2026
Here's Why You Should Retain OPK Stock in Your Portfolio for NowZacks Investment Research · Sep 28, 2026OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 27, 2026 | -$0.08 | -$0.01 | Beat |
| Apr 28, 2026 | -$0.07 | -$0.07 | Beat |
| Feb 26, 2026 | -$0.07 | -$0.04 | Beat |
| Oct 29, 2025 | -$0.02 | $0.03 | Beat |
| Jul 31, 2025 | -$0.12 | -$0.19 | Miss |
| Apr 30, 2025 | -$0.06 | -$0.10 | Miss |